| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Gabriella De Salvo | Q61896822 |
| P2093 | author name string | Rupesh Agrawal | |
| Adnan Tufail | |||
| Dawn A Sim | |||
| Pearse A Keane | |||
| Srini Goverdhan | |||
| P2860 | cites work | The macular mapping test: a reliability study. | Q24813545 |
| Retinal imaging in the twenty-first century: state of the art and future directions | Q38256682 | ||
| The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity | Q39264662 | ||
| Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration | Q39719946 | ||
| Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study | Q40018958 | ||
| Earliest symptoms of diseases of the macula | Q40929286 | ||
| Early detection of glaucoma by means of a novel 3D computer-automated visual field test | Q41131285 | ||
| Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation | Q41870812 | ||
| Feasibility of a novel remote daily monitoring system for age-related macular degeneration using mobile handheld devices: results of a pilot study. | Q42596149 | ||
| Incidence of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation | Q43030487 | ||
| Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration | Q44443126 | ||
| Variation of the Hyperacuity Gap Function with Age | Q44495556 | ||
| Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. | Q44580649 | ||
| Assessment of parafoveal function in maculopathy: a comparison between the Macular Mapping Test and kinetic Manual Perimetry | Q44656246 | ||
| Scotomas of age-related macular degeneration detected and characterized by means of a novel three-dimensional computer-automated visual field test | Q44706197 | ||
| Time trends in the incidence and causes of blindness in Israel | Q44899132 | ||
| Patterns and costs associated with progression of age-related macular degeneration | Q44977492 | ||
| Quantitative analysis of central visual field defects in macular edema using three-dimensional computer-automated threshold Amsler grid testing | Q45291334 | ||
| Distinguishing wet from dry age-related macular degeneration using three-dimensional computer-automated threshold Amsler grid testing | Q45301423 | ||
| Threshold Amsler grid testing in diabetic retinopathy. | Q45987375 | ||
| Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). | Q46102122 | ||
| Characterizing ethambutol-induced optic neuropathy with a 3D computer-automated threshold Amsler grid test | Q46313500 | ||
| Three-dimensional computer-automated threshold Amsler grid test | Q46461023 | ||
| Progression of lesion size in untreated eyes with exudative age-related macular degeneration: a meta-analysis using Lineweaver-Burk plots | Q46494897 | ||
| Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. | Q46732913 | ||
| Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results | Q46940817 | ||
| Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration | Q46956320 | ||
| Lesion location influences perception of homonymous scotomata during flickering random dot pattern stimulation | Q48429729 | ||
| The spatial sense of the eye. Proctor lecture | Q48548450 | ||
| Red dots visual field test with blue on yellow & blue on red macula test grid | Q50484788 | ||
| Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010. | Q50555531 | ||
| Detection and recognition of radial frequency patterns. | Q52226989 | ||
| Changes in eye care utilization following an eye health promotion campaign | Q57245036 | ||
| The Neovascular Age-Related Macular Degeneration Database | Q59305421 | ||
| White noise field campimetry. A new form of perimetric examination | Q68472539 | ||
| Earliest symptoms caused by neovascular membranes in the macula | Q68957139 | ||
| Threshold Amsler grid testing. Cross-polarizing lenses enhance yield | Q70025981 | ||
| Hyperacuity perimetry. Assessment of macular function through ocular opacities | Q70580523 | ||
| A modified Amsler grid. A self-assessment test for patients with macular disease | Q72663890 | ||
| Shape discrimination in age-related macular degeneration | Q74199449 | ||
| Comparison of the original Amsler grid with the modified Amsler grid: result for patients with age-related macular degeneration | Q81810746 | ||
| Don't lose sight of age-related macular degeneration: the need for increased awareness in Singapore | Q82745190 | ||
| Preferential hyperacuity perimeter in assessing responsiveness to ranibizumab therapy for exudative age-related macular degeneration | Q83022258 | ||
| Time to first treatment: The significance of early treatment of exudative age-related macular degeneration | Q83079783 | ||
| Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration | Q84353129 | ||
| Preferential hyperacuity perimeter as a functional tool for monitoring exudative age-related macular degeneration in patients treated by intravitreal ranibizumab | Q84874587 | ||
| OCT angiography: the next era of OCT technology emerges | Q85702927 | ||
| Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design - HOME Study report number 1 | Q87298378 | ||
| Optical coherence tomography | Q29617481 | ||
| A brief history of macular grids: from Thomas Reid to Edvard Munch and Marc Amsler. | Q30326121 | ||
| Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration | Q30582809 | ||
| The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London Survey | Q31058996 | ||
| Scanning laser entoptic perimetry for the detection of age-related macular degeneration | Q31126206 | ||
| Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study | Q33223098 | ||
| Comparison of clinically relevant findings from high-speed fourier-domain and conventional time-domain optical coherence tomography | Q33442302 | ||
| Estimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in Australia by ranibizumab treatment | Q33825687 | ||
| Patients' knowledge and perspectives on wet age-related macular degeneration and its treatment | Q33837372 | ||
| Binocular optical coherence tomography | Q33971725 | ||
| Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). | Q34092454 | ||
| Evaluation of age-related macular degeneration with optical coherence tomography | Q34294420 | ||
| Phase-variance optical coherence tomography: a technique for noninvasive angiography | Q34309542 | ||
| Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration | Q34408329 | ||
| Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration | Q34437164 | ||
| Retinal, anterior segment and full eye imaging using ultrahigh speed swept source OCT with vertical-cavity surface emitting lasers | Q34480867 | ||
| Occult subretinal new vessels in age-related macular degeneration. Natural History and early laser treatment | Q34594201 | ||
| Reproducibility of a long-range swept-source optical coherence tomography ocular biometry system and comparison with clinical biometers | Q34767160 | ||
| Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population | Q35590105 | ||
| Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapy | Q35593174 | ||
| Choroidal neovascularization | Q35688110 | ||
| Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration | Q35820366 | ||
| Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy | Q36592901 | ||
| The Amsler chart: absence of evidence is not evidence of absence | Q36745241 | ||
| Validity and interpretation of Amsler grid reports | Q36785140 | ||
| The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis | Q36901314 | ||
| Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy | Q37095340 | ||
| Recent progress in macular function self-assessment | Q37143541 | ||
| Macular function surveillance revisited | Q37199464 | ||
| Handheld ultrahigh speed swept source optical coherence tomography instrument using a MEMS scanning mirror | Q37476899 | ||
| Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis | Q37487873 | ||
| Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study | Q37570185 | ||
| Recent developments in the treatment of age-related macular degeneration | Q37679956 | ||
| The role of proteases and inflammatory molecules in triggering neovascular age-related macular degeneration: basic science to clinical relevance | Q38209275 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 353-366 | |
| P577 | publication date | 2015-02-17 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration | |
| P478 | volume | 9 |
| Q52689321 | A Tablet-Based Retinal Function Test in Neovascular Age-Related Macular Degeneration Eyes and At-Risk Fellow Eye. |
| Q30489873 | An Eye on Age-Related Macular Degeneration: The Role of MicroRNAs in Disease Pathology. |
| Q89227768 | Baseline Predictors for Five-Year Visual Acuity Outcomes in the Comparison of AMD Treatment Trials |
| Q89593937 | CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: An Expert Panel Consensus |
| Q37456542 | Collaborative care of non-urgent macular disease: a study of inter-optometric referrals |
| Q41382804 | Defining the Relationships Among Retinal Function, Layer Thickness and Visual Behavior During Oxidative Stress-Induced Retinal Degeneration |
| Q38816237 | Diabetic choroidopathy: a review of the current literature |
| Q104795269 | False alarms and the positive predictive value of smartphone-based hyperacuity home monitoring for the progression of macular disease: a prospective cohort study |
| Q47355167 | Gaming to improve vision: 21st century self-monitoring for patients with age-related macular degeneration. |
| Q104795272 | Identifying early symptoms of choroidal neovascularisation in second eyes of patients with unilateral wet age related macular degeneration using a telephone evaluation method |
| Q26824335 | Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development |
| Q26766573 | Ocular ultrasonography focused on the posterior eye segment: what radiologists should know. |
| Q38796584 | Performance, usability and comparison of two versions of a new macular vision test: the handheld Radial Shape Discrimination test. |
| Q55009931 | Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan. |
| Q50013368 | Reasons for delayed and discontinued therapy in age-related macular degeneration |
| Q91676618 | Reliability and diagnostic performance of a novel mobile app for hyperacuity self-monitoring in patients with age-related macular degeneration |
| Q61796605 | Scotopic contour and shape discrimination using radial frequency patterns |
| Q50903375 | The Finnish national guideline for diagnosis, treatment and follow-up of patients with wet age-related macular degeneration. |
| Q98892379 | The Muranga Teleophthalmology Study: A Comparison of Virtual (Teleretina) Assessment with in-person Clinical Examination to Diagnose Diabetic Retinopathy and Age-related Macular Degeneration in Kenya |
| Q88556853 | [Intravitreal ranibizumab for the treatment of retinal angiomatous proliferation] |
Search more.